What is Pfizer's equity method investments (note 11)?

Pfizer (PFE) reported equity method investments (note 11) of $237M in Q1 2026.

How has Pfizer's equity method investments (note 11) changed year-over-year?

Pfizer's equity method investments (note 11) increased by 5.8% year-over-year, from $224M to $237M.

What is the long-term trend for Pfizer's equity method investments (note 11)?

Over 5 years (2020 to 2025), Pfizer's equity method investments (note 11) has grown at a -57.5% compound annual growth rate (CAGR), from $16.86B to $235M.

Pfizer PFE Equity method investments (Note 11)

Equity method investments (Note 11) at other companies

Royalty PharmaRPRX

——

AbbottABT

——

Other financials

Income statement

See full

Revenue$14.5B+5.4%

Gross profit$10.9B+0.3%

Net income$2.7B-9.4%

EPS (diluted)$0.47-9.6%

Balance sheet

See full

Cash & equivalents$1.8B+18.8%

Total debt$64.4B+5.0%

Total equity$90.1B-0.3%

Total assets$207.62B-0.2%

Cash flow

See full

Operating cash flow$2.6B+12.0%

CapEx$436.0M-22.7%

Free cash flow$2.2B+23.0%

Valuation

See full

Market cap$143.68B+11.1%

Enterprise value$206.35B+9.2%

P/E11.9×—

P/S2.3×+0.2×

Profitability

See full

Gross margin73.5%+1.2pp

Net margin15.7%—

Returns & leverage

See full

Return on equity10.6%—

Debt / equity0.7×0.0×

Current ratio1.2×0.0×

Where this comes from

Reported directly by Pfizer in its filing.

Tagged under the XBRL concept us-gaap:EquityMethodInvestments.

The official record: Pfizer’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pfizer's equity method investments (note 11).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Pfizer's equity method investments (note 11)?: Pfizer (PFE) reported equity method investments (note 11) of $237M in Q1 2026.
How has Pfizer's equity method investments (note 11) changed year-over-year?: Pfizer's equity method investments (note 11) increased by 5.8% year-over-year, from $224M to $237M.
What is the long-term trend for Pfizer's equity method investments (note 11)?: Over 5 years (2020 to 2025), Pfizer's equity method investments (note 11) has grown at a -57.5% compound annual growth rate (CAGR), from $16.86B to $235M.